SPL
Click for more information
0.00% 9.7¢ starpharma holdings limited

BV article, page-3

  1. RELAYER
    380 Posts.
    lightbulb Created with Sketch. 2
    clock Created with Sketch.
    01/09/16
    08:59
    Post #: 18845535
    The study was supported by Symbiomix. Dr. Schwebke is a consultant for Symbiomix and receives funding from Alfa Wassermann and Starpharma, among others. Dr. Hillier is coprincipal investigator of the Microbicide Trials Network, sponsored by the National Institutes of Health
    SPL Price at posting: 70.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS High-grade copper assays continue to impress—resource update coming soon
right-arrow Created with Sketch.
NEWS Gold mineralisation discovered along major shear zone at Challa Gold Project, confirming two new intersections in latest aircore drilling
right-arrow Created with Sketch.
NEWS Large-scale copper discovery confirmed with high-grade assays—significant potential for major sedimentary-hosted copper deposits
right-arrow Created with Sketch.
NEWS Significant increase in revenue from faster NDIS approvals and launch of new leasing programs
right-arrow Created with Sketch.
NEWS Step out drilling confirms high-grade cobalt & associated copper at Bald Hill
right-arrow Created with Sketch.
NEWS Regulatory approval granted for drilling at high-grade lead and silver project—drilling set to begin soon
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.7¢ 		Change
0.000(0.00%) 		Mkt cap ! $40.48M
Open High Low Value Volume
9.9¢ 9.9¢ 9.5¢ $35.24K 364.0K

Buyers (Bids)

No. Vol. Price($)
3 18326 9.5¢
 

Sellers (Offers)

Price($) Vol. No.
9.8¢ 15262 2
View Market Depth
Last trade - 16.10pm 04/10/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.